Precision Neuroscience raised $250M to expand Layer 7 clinical work, FDA review, manufacturing and commercialization for brain-computer interface systems.
Michael Mager
CEO
Mark Hettick
Co-Founder
Demetrios Papageorgiou
Co-Founder
Benjamin Rapoport
Chief Science Officer